PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-70.15%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-60.19%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-145.06%
Negative EBIT growth while 6247.T is at 31.71%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-176.21%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-205.44%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-204.18%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-204.18%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-88.28%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-88.28%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-47.59%
Negative 3Y CAGR while 6247.T stands at 17.77%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
Positive long-term OCF/share growth while 6247.T is negative. John Neff would see a structural advantage in sustained cash generation.
100.00%
Positive OCF/share growth while 6247.T is negative. John Neff might see a comparative advantage in operational cash viability.
No Data
No Data available this quarter, please select a different quarter.
94.08%
Positive 10Y CAGR while 6247.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
94.08%
Positive 5Y CAGR while 6247.T is negative. John Neff might view this as a strong mid-term relative advantage.
71.55%
Positive short-term CAGR while 6247.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
179.77%
3Y equity/share CAGR above 1.5x 6247.T's 16.28%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.60%
Firm’s AR is declining while 6247.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
89.37%
Inventory growth well above 6247.T's 11.29%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
24.71%
Positive asset growth while 6247.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.96%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
96.39%
Debt growth of 96.39% while 6247.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-100.00%
Our R&D shrinks while 6247.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-10.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.